At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of Effectiveness and Safety of Belotero Balance® (+) Lidocaine for Volume Augmentation of the Infraorbital Hollow
In Brief
A clinical study evaluating Belotero Balance (+) Lidocaine, needle, Belotero Balance (+) Lidocaine, cannula, and 2 other interventions for Volume Loss in the Infraorbital Hollow Area. Completed, enrolled 150 participants across 9 sites in 2 countries.
Detailed Summary
* Confirm the effectiveness of Belotero Balance® (+) Lidocaine (BBL) injection for the correction of volume loss in the infraorbital hollow (IOH) area by demonstrating superiority to untreated control. * Confirm the safety of BBL injection for the correction of volume loss in the IOH area.
Study Details
Timeline
Interventions
Injection of Belotero Balance (+) Lidocaine to the infraorbital hollows using needles
Injection of Belotero Balance (+) Lidocaine into the infraorbital hollows using cannulas
Untreated-control, followed by delayed-treatment with Belotero Balance (+) Lidocaine (injection of Belotero Balance (+) Lidocaine to the infraorbital hollows using needles)
Untreated-control, followed by delayed-treatment with Belotero Balance (+) Lidocaine (injection of Belotero Balance (+) Lidocaine to the infraorbital hollows using cannulas)